Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China · Delayed Price · Currency is CNY 6.65
+0.09 (1.37%)
Feb 4, 2026, 3:04 PM CST
SHE:000153 Revenue
Anhui Fengyuan Pharmaceutical had revenue of 1.10B CNY in the quarter ending September 30, 2025, with 15.15% growth. This brings the company's revenue in the last twelve months to 4.15B, down -3.81% year-over-year. In the year 2024, Anhui Fengyuan Pharmaceutical had annual revenue of 4.28B with 0.21% growth.
Revenue (ttm)
4.15B
Revenue Growth
-3.81%
P/S Ratio
0.73
Revenue / Employee
913.33K
Employees
4,542
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.28B | 9.18M | 0.21% |
| Dec 31, 2023 | 4.28B | 271.42M | 6.78% |
| Jan 1, 2023 | 4.00B | 351.80M | 9.63% |
| Jan 1, 2022 | 3.65B | 331.03M | 9.97% |
| Dec 31, 2020 | 3.32B | 83.12M | 2.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Yibai Pharmaceutical | 1.91B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 914.65M |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Ginwa Enterprise (Group) | 550.44M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |